Impact of Percoll purification on isolation of primary human hepatocytes-Reference-Cited by-同舟云学术

Impact of Percoll purification on isolation of primary human hepatocytes

Published:2019-04-25 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Horner R.^ORCID,Gassner J. G. M. V.,Kluge M.,Tang P.,Lippert S.,Hillebrandt K. H.^ORCID,Moosburner S.^ORCID,Reutzel-Selke A.,Pratschke J.,Sauer I. M.^ORCID,Raschzok N.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-43042-8.pdf

Reference45 articles.

1. Gómez-Lechón, M. J., Castell, J. V. & Donato, M. T. The use of hepatocytes to investigate drug toxicity. Methods Mol Biol 640, 389–415 (2010).

2. Hengstler, J. G. et al. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug metabolism reviews 32(1), 81–118 (2000).

3. Russell, W. M. S. & Burch, R. L. The principles of humane experimental technique. Methuen and Co ltd., United Kingdom (1959).

4. Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8), 1315–530 (2013).

5. Vinken, M., Vanhaecke, T. & Rogiers, V. Primary hepatocyte cultures as in vitro tools for toxicity testing: quo vadis? Toxicol In Vitro. 26(3), 541–4 (2012).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rebuilding the microenvironment of primary tumors in humans: a focus on stroma;Experimental & Molecular Medicine;2024-03-05

2. Protocol to establish an oviduct epithelial cell line derived from Gallus gallus using Percoll for in vitro validation of recombinant proteins;STAR Protocols;2023-09

3. Tissue-Engineered Hepatocyte Sheets Supplemented with Adipose-Derived Stem Cells;Tissue Engineering Part A;2023-07-01

4. The COP9 Signalosome Variant CSNCSN7A Stabilizes the Deubiquitylating Enzyme CYLD Impeding Hepatic Steatosis;Livers;2021-07-27

5. From Donor to the Lab: A Fascinating Journey of Primary Cell Lines;Frontiers in Cell and Developmental Biology;2021-07-22